医薬品におけるジェネレーティブ人工知能（AI）の世界市場レポート 2025年

医薬品におけるジェネレーティブ人工知能（AI）市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年の年間平均成長率（CAGR）は31.0％で、71億6,000万米ドルに成長します。予測期間の成長は、疾患の早期発見、規制支援、ガイドラインの重視、計算能力の向上、医薬品開発コストの増加、データ利用可能性の増加などに起因すると考えられます。予測期間における主な動向には、ブロックチェーンとAIの統合、高度なデータ統合、疾患診断の強化、薬剤の自動再利用、リアルタイムの臨床試験最適化などがあります。

個別化医療が重視されるようになったことで、製薬業界では生成型人工知能（AI）の進歩が促進されようとしています。個別化医療は、遺伝的要因、環境要因、ライフスタイル要因など、患者個人の特性に基づいて治療をカスタマイズするものです。このような注目の高まりは、個人のニーズに合わせたより正確で効果的な治療を促進する遺伝子研究と技術の進歩によって支えられています。ジェネレーティブAIは、カスタマイズされた薬物療法の開発を可能にすることで、治療効果と患者の転帰を向上させ、この分野で重要な役割を果たしています。例えば、個別化医療連合（Personalized Medicine Coalition）は2024年2月、FDAが2023年に希少疾患に対する新規の個別化治療を16件承認したと報告しました。その結果、個別化医療の台頭が製薬分野におけるジェネレーティブAIの成長に拍車をかけています。

ジェネレーティブAI医薬品市場の主要企業は、創薬プロセスを強化するAIヘルスケア・マイクロサービスなどの革新的な製品を生み出しています。こうしたモジュール式のクラウドベースのサービスは、AIを利用して創薬、医療画像、診断などさまざまなヘルスケア機能を改善します。例えば、エヌビディア・コーポレーションは2024年3月、最適化されたNIM AIモデルとワークフロー、クラウドネイティブ・アプリケーション用APIを備えたジェネレーティブAIマイクロサービスを発表しました。これらのマイクロサービスは、画像処理、自然言語処理、音声認識、デジタル生物学機能などの高度な機能を提供します。Parabricks、MONAI、NeMo、Riva、MetropolisなどのツールがCUDA-Xマイクロサービスとして提供され、創薬やゲノミクスのワークフローを改善します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医薬品におけるジェネレーティブ人工知能（AI） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：成長率分析
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場の実績：規模と成長, 2019-2024
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場の予測：規模と成長, 2024-2029, 2034F
• 世界医薬品におけるジェネレーティブ人工知能（AI）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小分子
• 巨大分子
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ディープラーニング
• 自然言語処理
• クエリメソッド
• コンテキスト認識処理
• その他のテクノロジー
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験調査
• 創薬
• 研究開発
• その他の用途
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場、小分子のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品の発見と設計
• 低分子化合物のリード最適化
• 薬物動態と毒性の予測モデリング
• 化合物ライブラリの仮想スクリーニング
• 低分子治療における個別化医療アプローチ
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場、巨大分子のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物製剤の発見と開発
• モノクローナル抗体の設計
• タンパク質工学と最適化
• ワクチン開発と最適化
• バイオ医薬品の有効性と安全性の予測モデル

第7章 地域別・国別分析

• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品におけるジェネレーティブ人工知能（AI）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品におけるジェネレーティブ人工知能（AI）市場：競合情勢
• 医薬品におけるジェネレーティブ人工知能（AI）市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Fujitsu Limited
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Gilead Sciences Inc.
• NVIDIA Corporation
• Conduent Incorporated
• XtalPi Inc.
• Insilico Medicine Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品におけるジェネレーティブ人工知能（AI）市場2029：新たな機会を提供する国
• 医薬品におけるジェネレーティブ人工知能（AI）市場2029：新たな機会を提供するセグメント
• 医薬品におけるジェネレーティブ人工知能（AI）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Generative artificial intelligence (AI) in the pharmaceutical industry utilizes advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and streamline drug discovery. It employs techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

Generative AI in pharmaceuticals primarily focuses on two types of molecules such as small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily penetrate cells and influence biological processes. Technologies involved include deep learning, natural language processing, querying methods, and context-aware processing, which are applied in areas such as clinical trial research, drug discovery, and research and development.

The generative artificial intelligence (AI) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in pharmaceutical market statistics, including generative artificial intelligence (AI) in pharmaceutical industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in pharmaceutical market share, detailed generative artificial intelligence (AI) in pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in pharmaceutical industry. This generative artificial intelligence (AI) in pharmaceutical market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generative artificial intelligence (AI) in pharmaceutical market size has grown exponentially in recent years. It will grow from $1.85 $ billion in 2024 to $2.43 $ billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to growth in computational power, the rise of big data in healthcare and pharmaceuticals, increased research and development investment, improved data quality and integration, and expansion of cloud computing.

The generative artificial intelligence (AI) in pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $7.16 $ billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to a focus on early disease detection, regulatory support, and guidelines, improved computational power, growth in drug development costs, increased data availability. Major trends in the forecast period include blockchain and AI integration, advanced data integration, enhanced disease diagnosis, automated drug repurposing, real-time clinical trial optimization.

The growing emphasis on personalized medicine is set to drive the advancement of generative artificial intelligence (AI) within the pharmaceutical industry. Personalized medicine customizes medical treatments based on individual patient characteristics, including genetic, environmental, and lifestyle factors. This increasing focus is supported by advancements in genetic research and technology, which facilitate more precise and effective treatments tailored to individual needs. Generative AI plays a crucial role in this field by enabling the development of customized drug therapies, thereby enhancing treatment efficacy and patient outcomes. For example, the Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 novel personalized therapies for rare diseases in 2023, a significant increase from six approvals in 2022. Consequently, the rise in personalized medicine is fueling the growth of generative AI in the pharmaceutical sector.

Leading companies in the generative AI pharmaceutical market are creating innovative products such as AI healthcare microservices to enhance drug discovery processes. These modular, cloud-based services use AI to improve various healthcare functions, such as drug discovery, medical imaging, and diagnostics. For instance, Nvidia Corporation introduced generative AI microservices in March 2024, featuring optimized NIM AI models and workflows with APIs for cloud-native applications. These microservices offer advanced capabilities in imaging, natural language processing, and speech recognition, as well as digital biology functions. Tools such as Parabricks, MONAI, NeMo, Riva, and Metropolis are available as CUDA-X microservices, improving workflows in drug discovery and genomics.

In June 2023, Eli Lilly and Company, a US-based pharmaceutical and biomedical research firm, entered into a partnership with XtalPi Inc. This collaboration aims to utilize XtalPi's advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates for a specific, undisclosed target. The partnership will leverage XtalPi's technology to explore extensive chemical spaces and identify promising drug candidates through iterative design, synthesis, testing, and analysis, all supported by autonomous robotic systems for enhanced efficiency and precision. XtalPi Inc., based in China, specializes in AI-powered drug research and development.

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2023. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in pharmaceutical market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative artificial intelligence (ai) in pharmaceutical market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative artificial intelligence (ai) in pharmaceutical ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative artificial intelligence (ai) in pharmaceutical market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Small Molecule; Large Molecule
• 2) By Technology: Deep Learning; Natural Language Processing; Querying Method; Context-Aware Processing; Other Technologies
• 3) By Application: Clinical Trial Research; Drug Discovery; Research And Development; Other Applications
• Subsegments:
• 1) By Small Molecule: Drug Discovery And Design; Lead Optimization For Small Molecule Compounds; Predictive Modeling For Pharmacokinetics And Toxicity; Virtual Screening Of Compound Libraries; Personalized Medicine Approaches For Small Molecule Therapies
• 2) By Large Molecule: Biologics Discovery And Development; Monoclonal Antibody Design; Protein Engineering And Optimization; Vaccine Development And Optimization; Predictive Models For Biopharmaceutical Efficacy And Safety.
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Growth Analysis And Strategic Analysis Framework

• 5.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Rate Analysis
• 5.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Generative Artificial Intelligence (AI) In Pharmaceutical Total Addressable Market (TAM)

6. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

• 6.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deep Learning
• Natural Language Processing
• Querying Method
• Context-Aware Processing
• Other Technologies
• 6.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Research
• Drug Discovery
• Research And Development
• Other Applications
• 6.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Design
• Lead Optimization For Small Molecule Compounds
• Predictive Modeling For Pharmacokinetics And Toxicity
• Virtual Screening Of Compound Libraries
• Personalized Medicine Approaches For Small Molecule Therapies
• 6.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics Discovery And Development
• Monoclonal Antibody Design
• Protein Engineering And Optimization
• Vaccine Development And Optimization
• Predictive Models For Biopharmaceutical Efficacy And Safety

7. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

• 7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 9.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 9.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 10.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 11.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 11.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 12.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 13.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 14.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 14.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 15.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 15.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 16.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 17.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 18.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 19.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 20.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 21.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 21.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 22.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 23.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 23.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 24.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 24.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 25.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 25.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 26.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 26.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 27.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 28.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 28.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

• 29.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview
• 29.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

• 30.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape
• 30.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis AG
• 31.6. GlaxoSmithKline plc
• 31.7. Fujitsu Limited
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lilly and Company
• 31.10. Amgen Inc.
• 31.11. Gilead Sciences Inc.
• 31.12. NVIDIA Corporation
• 31.13. Conduent Incorporated
• 31.14. XtalPi Inc.
• 31.15. Insilico Medicine Inc.

32. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

34. Recent Developments In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

35. Generative Artificial Intelligence (AI) In Pharmaceutical Market High Potential Countries, Segments and Strategies

• 35.1 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer